linkedin Created with Sketch. twitter Created with Sketch. instagram Created with Sketch.
Shape
← Back to portfolio Porfolio / Caristo Diagnostics

Caristo Diagnostics

A medical imaging company

Company overview

Caristo was founded in 2018 by Cardiologists at the University of Oxford, following a decade of scientific research and technical development, and is now a leader in supporting the transformation of healthcare from treatment-based medicine to prevention. Caristo’s technology aims to revolutionise diagnosis and treatment, enabling physicians to identify patients with the highest heart attack risk and prescribe effective, personalised treatments that can prevent a fatal heart attack.

To date the company has raised a total of £10.2 million, they recently closed a successful investment round led by BGF and existing investors including Oxford Sciences Innovation (OSI), Longwall Ventures and the Oxford Technology & Innovation Fund (OTIF).

New products in the pipeline will also be capable of predicting stroke and diabetes risk, years in advance.

Company information

Head office
  • Oxford
CEO
  • Dr Cheerag Shirodaria
BGF office
Investment date
  • Mar 2021